CRBU · Caribou Biosciences, Inc. · Documents

$0.38 -0.01 (-2.69%) At close · Nov 12

Russell 2000 member Rebalance outlook locked

Market Cap

$41.08M

108.04M

Volume · Nov 12 1.54M Avg daily vol (3M) 2.72M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022

Aug 9

Current report 8-K

Financial results, Other events

Aug 9

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $4.19M ▲ 184.0% Net loss $26.7M Diluted EPS -$0.44

Aug 9

Registration statement S-3

Registration statement

Jul 18

Current report 8-K/A Events of May 11

Director or officer change, or executive pay

Jul 15

Current report 8-K

Other events

Jun 10

Current report 8-K

Regulation FD disclosure, Other events

Jun 1

Current report 8-K

Regulation FD disclosure

May 12

Current report 8-K

Regulation FD disclosure, Other events

May 11

Current report 8-K Events of May 10

Director or officer change, or executive pay, Regulation FD disclosure

May 9

Current report 8-K

Financial results

May 9

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $2.66M ▲ 68.0% Net loss $19.09M

Apr 25

Current report 8-K

Regulation FD disclosure

Mar 21

Current report 8-K

Financial results

Mar 21

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $9.6M ▼ 22.4% Net loss $66.92M

Jan 19

Current report 8-K Events of Jan 13

Entered into a material agreement, New debt or off-balance-sheet obligation

Jan 18

Current report 8-K

Other events

2021

Nov 9

Current report 8-K

Financial results

Nov 9

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $3.98M ▲ 232.0% Net loss $20.97M

Nov 8

Current report 8-K Events of Nov 4

Director or officer change, or executive pay, Regulation FD disclosure

Sep 29

Current report 8-K Events of Sep 24

Director or officer change, or executive pay, Regulation FD disclosure

Sep 2

Current report 8-K

Financial results

Sep 2

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $0 Net loss $14.31M

Aug 25

Current report 8-K Events of Aug 24

Director or officer change, or executive pay, Regulation FD disclosure

Jul 28

Current report 8-K Events of Jul 22

Unregistered sale of equity, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Other events

Jul 22

Registration statement S-1/A

Registration statement

Jul 19

Registration statement S-1/A

Registration statement

Jul 1

Registration statement S-1

Registration statement

Showing 101–127 of 127 documents

Key facts CIK 1619856 CUSIP 142038108 13F (30d) 94 filings 81 filers Visit website Investor relations